Cohen, P. R., Tomson, B. N., Elkin, S. K., Marchlik, E., Carter, J. L., & Kurzrock, R. (2016). Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: Implications for targeted therapeutics. Oncotarget.

Cohen, Philip R., Brett N. Tomson, Sheryl K. Elkin, Erica Marchlik, Jennifer L. Carter, and Razelle Kurzrock. "Genomic Portfolio of Merkel Cell Carcinoma As Determined By Comprehensive Genomic Profiling: Implications for Targeted Therapeutics." Oncotarget 2016.

Cohen, Philip R., et al. "Genomic Portfolio of Merkel Cell Carcinoma As Determined By Comprehensive Genomic Profiling: Implications for Targeted Therapeutics." Oncotarget 2016.